Dr. Eva Feldman, a physician and researcher at the University of Michigan in Ann Arbor, will be honored as one of America’s top doctors at the National Physician of the Year Awards held next week in New York.
“It is such an honor to be recognized, but this is truly the result of tremendous teamwork,” Feldman says. “The University of Michigan attracts such talented and dedicated people to serve our patients in every way, through brilliant staff, cutting-edge research, and world-class facilities. I feel deeply privileged to be a practicing clinician-scientist at U-M.”
Feldman, a professor of neurology at U-M, director of the A. Alfred Taubman Medical Research Institute, and director of the program for neurology research and discovery at the institute, is one of three recipients of the award.
Feldman is the principal investigator of the first clinical trial of intraspinal transplantation of stem cells in patients with ALS, a nervous system disease that weakens muscles and impacts physical function. To date, 30 patients have received up to 16 million stem cells injected directly to their spinal cords and a similar therapy is being studied for use in patients with Alzheimer’s disease.
Out of the 900,000 licensed physicians in the United States, 47,000 make the “Best Doctors in America” directories, and out of those, only three are selected annually for the Castle Connolly Top Doctors award. Castle Connolly Medical annually solicits nominations from thousands of physicians across the country and the leadership of more than 1,000 hospitals to identify physicians who have made significant and cutting-edge contributions to their areas of medicine for its Castle Connolly Top Doctors awards.
Feldman has published more than 325 original peer-reviewed articles, 60 book chapters, and three books. She served as President of the American Neurological Association from 2011 to 2013, was elected to the National Academy of Medicine in 2014.
